News & Updates

Show Multimedia Only
MRI- vs CT- guided radiotherapy for localized prostate cancer linked to lower toxicity, symptom burden MRI- vs CT- guided radiotherapy for localized prostate cancer linked to lower toxicity, symptom burden

MRI- vs CT- guided radiotherapy for localized prostate cancer linked to lower toxicity, symptom burden

19 Jan 2023 byJairia Dela Cruz

Magnetic resonance imaging (MRI) guidance in stereotactic body radiotherapy (SBRT) for prostate cancer offers significant advantage over computed tomography (CT) guidance, with lower physician-scored toxic effects and patient-reported symptom burden, according to the results of the phase III MIRAGE* study.

19 Jan 2023
Can RA patients taper MTX from targeted therapy?

Can RA patients taper MTX from targeted therapy?

18 Jan 2023

A recent study has found that tapering methotrexate (MTX) from targeted therapy in patients with controlled rheumatoid arthritis (RA) is feasible, but this may result in a 10-percent decrease in the ability to sustain remission for up to 18 months.

18 Jan 2023